MaSTherCell

Catalent Gosselies cell therapy site

Catalent adds Belgian site to cell and gene therapy portfolio

Catalent has acquired Bone Therapeutics' cell and gene therapy site in Gosselies, Belgium, to add to its growing "center of excellence" there.

Kyle Blankenship Oct 29, 2020 11:33am

Masthercell gene and cell manufacturing

Catalent laying out $315M to snatch another gene therapy CDMO

Feb 3, 2020 10:00am

Masthercell gene and cell manufacturing

Masthercell adds to global gene and cell manufacturing frenzy

Mar 26, 2019 10:50am